Arvind Sanger of Geosphere Capital Management discusses Trump’s tariff plans. These plans include potential hikes on pharmaceutical imports and Indian goods. China may have leverage due to rare earth elements and Trump’s desire for a meeting with Xi Jinping. India lacks a similar advantage. Sanger also addresses concerns about consistent FII selling and the need for domestic growth initiatives.
Recent Posts
- Bitcoin, Ethereum, Dogecoin Jump Alongside Stocks Amid Apple’s $100 Billion Investment Plan: Analyst Flags ‘Massive Resistance Wall’ For BTC
- 4 Stocks have formed a bearish death cross pattern; Are you holding any?
- 4 Fundamentally strong stocks that are trading in oversold zone with RSI below 30
- Asia Morning Briefing: BTC Slips Into Low-Liquidity “Air Gap” as Post-ATH Drift Continues
- Stock Market LIVE: GIFT Nifty Implies Slightly Higher Open; Hero MotoCorp, Dixon Tech Shares In Focus